DIABETIC RETINAL MICROANGIOPATHY

Clinical trials for DIABETIC RETINAL MICROANGIOPATHY explained in plain language.

Never miss a new study

Get alerted when new DIABETIC RETINAL MICROANGIOPATHY trials appear

Sign up with your email to follow new studies for DIABETIC RETINAL MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New eye drop trial aims to slow diabetic eye damage

Disease control Not yet recruiting

This very early study will test NPDR-01 eye drops in 10 people with non-proliferative diabetic retinopathy, a common diabetes-related eye condition. The goal is to see if the drops can reduce tiny, leaky blood vessels in the retina (microaneurysms) and slow the disease's progress…

Matched conditions: DIABETIC RETINAL MICROANGIOPATHY

Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

DIABETIC RETINAL MICROANGIOPATHY

Get alerted when new DIABETIC RETINAL MICROANGIOPATHY trials appear

New eye drop trial aims to slow diabetic eye damage